Catalog No. :
|
CL1228 |
Product Name :
|
Epirubicin Hydrochloride (Epirubicin HCl) |
CAS No. :
|
56390-09-1 |
Synonyms :
|
Epirubicin HCl || IMI 28 HCl | NSC 256942 HCl | 4'-epidoxorubicin HCl |
Chemical Name :
|
(8R,10S)-10-((2R,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-6,8,11-trihydroxy-7-(2-hydroxy-acetyl)-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione hydrochloride |
Molecular Formula :
|
C27H29NO11.HCl |
Molecular Weight :
|
579.98 |
Molecular Structure :
|
|
Appearance :
|
Pink to red solid |
Specification :
|
98+% |
Application :
|
Topoisomerase inhibitor | Apoptosis related activator |
Registration :
|
|
Storage Condition :
|
4°C, sealed storage, away from moisture and light |
Epirubicin HCl, a semisynthetic L-arabino
derivative of doxorubicin, is an antineoplastic agent by inhibiting
Topoisomerase. Epirubicin induces apoptosis.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.